![Peter Hovstadius](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter Hovstadius
Director Técnico/Científico/I+D en
LIPUM AB
.
Perfil
Peter Hovstadius currently works at Lipum AB, as Chief Medical Officer from 2024.
Dr. Hovstadius also formerly worked at Merck Sharp & Dohme AB, as Research Director, XNK Therapeutics AB, as Chief Medical Officer, and Novartis Sverige AB, as Chief Scientific Officer.
Dr. Hovstadius received his doctorate degree from the University of Uppsala.
Cargos activos de Peter Hovstadius
| Empresas | Cargo | Inicio |
|---|---|---|
| LIPUM AB | Director Técnico/Científico/I+D | 19/08/2024 |
Antiguos cargos conocidos de Peter Hovstadius.
| Empresas | Cargo | Fin |
|---|---|---|
Novartis Sverige AB
 Novartis Sverige AB Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical, ophthalmic and generic drugs | Director Técnico/Científico/I+D | - |
Merck Sharp & Dohme AB | Director Técnico/Científico/I+D | - |
CellProtect Nordic Pharmaceuticals AB
 CellProtect Nordic Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops cell-based therapies for treatment of severe diseases | Director Técnico/Científico/I+D | - |
Formación de Peter Hovstadius.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
13
Relaciones de 1er grado
5
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 5 |
|---|---|
University of Uppsala
 University of Uppsala Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Sverige AB
Novartis Sverige AB Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical, ophthalmic and generic drugs | Health Technology |
CellProtect Nordic Pharmaceuticals AB
CellProtect Nordic Pharmaceuticals AB Pharmaceuticals: MajorHealth Technology Develops cell-based therapies for treatment of severe diseases | Health Technology |
Lipum AB
 Lipum AB BiotechnologyHealth Technology Develops biological anti-inflammatory drugs | Health Technology |
Merck Sharp & Dohme AB |
- Bolsa de valores
- Insiders
- Peter Hovstadius
